New Concepts in Chronic Obstructive Pulmonary Disease

作者: Peter J. Barnes

DOI: 10.1146/ANNUREV.MED.54.101601.152209

关键词:

摘要: Chronic obstructive pulmonary disease (COPD) is a leading cause of death and disability but has only recently been explored from cellular molecular perspective. In COPD, chronic inflammation leads to fixed narrowing small airways alveolar wall destruction (emphysema). This characterized by increased numbers macrophages, neutrophils, cytotoxic T lymphocytes, the release multiple inflammatory mediators (lipids, chemokines, cytokines, growth factors). There also high level oxidative stress, which may amplify this inflammation. elastolysis probable involvement matrix metalloproteinases. The proteolysis in COPD an amplification normal response cigarette smoke. Unlike asthma, appears be resistant corticosteroids, prompting search for novel anti-inflammatory therapies that prevent relentless progression disease.

参考文章(103)
AINA NOGUERA, XAVIER BUSQUETS, JAUME SAULEDA, JOSE M VILLAVERDE, WILLIAM MacNEE, ALVAR GN AGUSTÍ, with the Technical Assistance of Carmen Santos, Expression of Adhesion Molecules and G Proteins in Circulating Neutrophils in Chronic Obstructive Pulmonary Disease American Journal of Respiratory and Critical Care Medicine. ,vol. 158, pp. 1664- 1668 ,(1998) , 10.1164/AJRCCM.158.5.9712092
Jørgen Vestbo, Suzanne S. Hurd, Alvar G. Agustí, Paul W. Jones, Claus Vogelmeier, Antonio Anzueto, Peter J. Barnes, Leonardo M. Fabbri, Fernando J. Martinez, Masaharu Nishimura, Robert A. Stockley, Don D. Sin, Roberto Rodriguez-Roisin, Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease American Journal of Respiratory and Critical Care Medicine. ,vol. 187, pp. 347- 365 ,(2013) , 10.1164/RCCM.201204-0596PP
A M Schols, P B Soeters, R Mostert, R J Pluymers, E F Wouters, Physiologic Effects of Nutritional Support and Anabolic Steroids in Patients with Chronic Obstructive Pulmonary Disease A Placebo-controlled Randomized Trial American Journal of Respiratory and Critical Care Medicine. ,vol. 152, pp. 1268- 1274 ,(1995) , 10.1164/AJRCCM.152.4.7551381
PAOLO PAREDI, SERGEI A. KHARITONOV, DAVID LEAK, SIMON WARD, DAVID CRAMER, PETER J. BARNES, Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. ,vol. 162, pp. 369- 373 ,(2000) , 10.1164/AJRCCM.162.2.9909025
HAJIME TAKIZAWA, MITSURU TANAKA, KAZUTAKA TAKAMI, TAKAYUKI OHTOSHI, KOJI ITO, MASARU SATOH, YASUMASA OKADA, FUMIHIRO YAMASAWA, KAZUHIKO NAKAHARA, AKIRA UMEDA, Increased Expression of Transforming Growth Factor- β 1 in Small Airway Epithelium from Tobacco Smokers and Patients with Chronic Obstructive Pulmonary Disease (COPD) American Journal of Respiratory and Critical Care Medicine. ,vol. 163, pp. 1476- 1483 ,(2001) , 10.1164/AJRCCM.163.6.9908135
M Roland, A Bhowmik, RJ Sapsford, TAR Seemungal, DJ Jeffries, TD Warner, JA Wedzicha, Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease Thorax. ,vol. 56, pp. 30- 35 ,(2001) , 10.1136/THORAX.56.1.30
MARINA SAETTA, SIMONETTA BARALDO, LAURA CORBINO, GRAZIELLA TURATO, FAUSTO BRACCIONI, FEDERICO REA, GIORGIO CAVALLESCO, GIUSEPPE TROPEANO, CRISTINA E. MAPP, PIERO MAESTRELLI, ADALBERTO CIACCIA, LEONARDO M. FABBRI, CD8 + ve Cells in the Lungs of Smokers with Chronic Obstructive Pulmonary Disease American Journal of Respiratory and Critical Care Medicine. ,vol. 160, pp. 711- 717 ,(1999) , 10.1164/AJRCCM.160.2.9812020
G. W. Chalmers, K. J. Macleod, S. Sriram, L. J. Thomson, C. McSharry, B. H. R. Stack, N. C. Thomson, Sputum endothelin-1 is increased in cystic fibrosis and chronic obstructive pulmonary disease. European Respiratory Journal. ,vol. 13, pp. 1288- 1292 ,(1999) , 10.1183/09031936.99.13612939
MASAKAZU ICHINOSE, HISATOSHI SUGIURA, SHUNSUKE YAMAGATA, AKIRA KOARAI, KUNIO SHIRATO, Increase in Reactive Nitrogen Species Production in Chronic Obstructive Pulmonary Disease Airways American Journal of Respiratory and Critical Care Medicine. ,vol. 162, pp. 701- 706 ,(2000) , 10.1164/AJRCCM.162.2.9908132